{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:13:58Z","timestamp":1790352838264,"version":"4.1.0"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1097\/mol.0b013e328364e85a","type":"journal-article","created":{"date-parts":[[2013,8,29]],"date-time":"2013-08-29T13:17:15Z","timestamp":1377782235000},"page":"426-437","source":"Crossref","is-referenced-by-count":32,"title":["Oxidation-specific epitopes as targets for biotheranostic applications in humans"],"prefix":"10.1097","volume":"24","author":[{"given":"Yury I.","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotirios","family":"Tsimikas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20211004","first-page":"915","article-title":"Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.","volume":"320","author":"Steinberg","year":"1989","journal-title":"N Engl J Med"},{"key":"R2-9-20211004","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.coph.2013.02.005","article-title":"Oxidation-specific epitopes and immunological responses translational biotheranostic implications for atherosclerosis.","volume":"13","author":"Leibundgut","year":"2013","journal-title":"Curr Opin Pharmacol"},{"key":"R3-9-20211004","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/nature10449","article-title":"Complement factor H binds malondialdehyde epitopes and protects from oxidative stress.","volume":"478","author":"Weismann","year":"2011","journal-title":"Nature"},{"key":"R4-9-20211004","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1161\/CIRCRESAHA.110.223875","article-title":"Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity.","volume":"108","author":"Miller","year":"2011","journal-title":"Circ Res"},{"key":"R5-9-20211004","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1172\/JCI63108","article-title":"Adaptive immunity in atherogenesis: new insights and therapeutic approaches.","volume":"123","author":"Lichtman","year":"2013","journal-title":"J Clin Invest"},{"key":"R6-9-20211004","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/978-90-481-8622-8_8","article-title":"Lipoprotein modification and macrophage uptake: role of pathologic cholesterol transport in atherogenesis.","volume":"51","author":"Miller","year":"2010","journal-title":"Subcell Biochem"},{"key":"R7-9-20211004","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.atherosclerosis.2009.09.002","article-title":"The haptoglobin 2-2 genotype is associated with increased redox active hemoglobin derived iron in the atherosclerotic plaque.","volume":"209","author":"Kalet-Litman","year":"2010","journal-title":"Atherosclerosis"},{"key":"R8-9-20211004","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jacc.2012.04.011","article-title":"Increased expression of oxidation-specific epitopes and apoptosis are associated with haptoglobin genotype: possible implications for plaque progression in human atherosclerosis.","volume":"60","author":"Purushothaman","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R9-9-20211004","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1194\/jlr.P030890","article-title":"Differential expression of oxidation-specific epitopes and apolipoprotein(a) in progressing and ruptured human coronary and carotid atherosclerotic lesions.","volume":"53","author":"van Dijk","year":"2012","journal-title":"J Lipid Res"},{"key":"R10-9-20211004","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1126\/science.1071059","article-title":"The danger model: a renewed sense of self.","volume":"296","author":"Matzinger","year":"2002","journal-title":"Science"},{"key":"R11-9-20211004","first-page":"1335","article-title":"Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans.","volume":"119","author":"Chou","year":"2009","journal-title":"J Clin Res"},{"key":"R12-9-20211004","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/j.jacc.2013.02.047","article-title":"Oxidation-specific biomarkers and risk of peripheral artery disease.","volume":"61","author":"Bertoia","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R13-9-20211004","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1016\/j.jacc.2012.08.979","article-title":"Oxidation-specific biomarkers, prospective 15-year cardiovascular and stroke outcomes, and net reclassification of cardiovascular events.","volume":"60","author":"Tsimikas","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R14-9-20211004","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2217\/bmm.11.60","article-title":"Oxidized phospholipids on apolipoprotein B-100(OxPLapoB) containing lipoproteins: A biomarker predicting cardiovascular disease and cardiovascular events.","volume":"5","author":"Taleb","year":"2011","journal-title":"Biomarkers Med"},{"key":"R15-9-20211004","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.amjcard.2009.09.052","article-title":"Relation of oxidative biomarkers, vascular dysfunction, and progression of coronary artery calcium.","volume":"105","author":"Ahmadi","year":"2010","journal-title":"Am J Cardiol"},{"key":"R16-9-20211004","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ypmed.2009.06.018","article-title":"Aged garlic extract supplemented with B vitamins, folic acid and L-arginine retards the progression of subclinical atherosclerosis: a randomized clinical trial.","volume":"49","author":"Budoff","year":"2009","journal-title":"Prev Med"},{"key":"R17-9-20211004","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.jacc.2010.04.048","article-title":"Oxidation-specific biomarkers, lipoprotein(a), and risk of fatal and nonfatal coronary events.","volume":"56","author":"Tsimikas","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"R18-9-20211004","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.jacc.2008.01.026","article-title":"The influence of pravastatin and atorvastatin on markers of oxidative stress in hypercholesterolemic humans.","volume":"51","author":"Ky","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R19-9-20211004","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1001\/jama.299.19.2287","article-title":"Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome.","volume":"299","author":"Holvoet","year":"2008","journal-title":"JAMA"},{"key":"R20-9-20211004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3164\/jcbn.11-00020R1","article-title":"Oxidized low-density lipoprotein as a biomarker of in vivo oxidative stress: from atherosclerosis to periodontitis.","volume":"51","author":"Itabe","year":"2012","journal-title":"J Clin Biochem Nutr"},{"key":"R21-9-20211004","doi-asserted-by":"crossref","first-page":"52841","DOI":"10.1074\/jbc.M310425200","article-title":"Lysine-phosphatidylcholine adducts in kringle V impart unique immunological and potential pro-inflammatory properties to human apolipoprotein(a).","volume":"278","author":"Edelstein","year":"2003","journal-title":"J Biol Chem"},{"key":"R22-9-20211004","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1194\/jlr.M800174-JLR200","article-title":"A novel function of lipoprotein a as a preferential carrier of oxidized phospholipids in human plasma.","volume":"49","author":"Bergmark","year":"2008","journal-title":"J Lipid Res"},{"key":"R23-9-20211004","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","article-title":"Lipoprotein(a) as a cardiovascular risk factor: current status.","volume":"31","author":"Nordestgaard","year":"2010","journal-title":"Eur Heart J"},{"key":"R24-9-20211004","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.jacc.2010.10.052","article-title":"Antisense oligonucleotide lowers plasma levels of apolipoprotein (a) and lipoprotein (a) in transgenic mice.","volume":"57","author":"Merki","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R25-9-20211004","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/MOL.0b013e3283598d81","article-title":"Emerging therapeutic agents to lower lipoprotein (a) levels.","volume":"23","author":"Kolski","year":"2012","journal-title":"Curr Opin Lipidol"},{"key":"R26-9-20211004","doi-asserted-by":"crossref","first-page":"E2037","DOI":"10.1016\/S0735-1097(13)62037-9","article-title":"Oxidized phospholipids on apolipoprotein(a) are only present on human Lp(a): Implications for understanding Lp(a) atherogenicity.","volume":"61","author":"Leibundgut","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R27-9-20211004","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cmet.2010.09.010","article-title":"Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress.","volume":"12","author":"Seimon","year":"2010","journal-title":"Cell Metab"},{"key":"R28-9-20211004","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1161\/CIRCULATIONAHA.108.836940","article-title":"Relationship of oxidized phospholipids on apolipoprotein B-100 particles to raceethnicity, apolipoprotein(a) isoform size, and cardiovascular risk factors: results from the Dallas Heart Study.","volume":"119","author":"Tsimikas","year":"2009","journal-title":"Circulation"},{"key":"R29-9-20211004","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.bbalip.2010.03.009","article-title":"Naturally occurring human plasminogen, like genetically related apolipoprotein(a), contains oxidized phosphatidylcholine adducts.","volume":"1801","author":"Edelstein","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"R30-9-20211004","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.jacc.2011.12.033","article-title":"Oxidized phospholipids are present on plasminogen, affect and increase following acute myocardial infarction.","volume":"59","author":"Leibundgut","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R31-9-20211004","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jacc.2010.09.023","article-title":"Targeted iron oxide particles for in vivo magnetic resonance detection of atherosclerotic lesions with antibodies directed to oxidation-specific epitopes.","volume":"57","author":"Briley-Saebo","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R32-9-20211004","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jacc.2011.10.881","article-title":"In vivo detection of oxidation-specific epitopes in atherosclerotic lesions using biocompatible manganese molecular magnetic imaging probes.","volume":"59","author":"Briley-Saebo","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R33-9-20211004","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1161\/CIRCULATIONAHA.107.757120","article-title":"Targeted molecular probes for imaging atherosclerotic lesions with magnetic resonance using antibodies that recognize oxidation-specific epitopes.","volume":"117","author":"Briley-Saebo","year":"2008","journal-title":"Circulation"},{"key":"R34-9-20211004","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.1172\/JCI57755","article-title":"In vivo visualization and attenuation of oxidized lipid accumulation in hypercholesterolemic zebrafish.","volume":"121","author":"Fang","year":"2011","journal-title":"J Clin Invest"},{"key":"R35-9-20211004","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/nm1102-1218","article-title":"Innate and acquired immunity in atherogenesis.","volume":"8","author":"Binder","year":"2002","journal-title":"Nat Med"},{"key":"R36-9-20211004","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1161\/CIRCULATIONAHA.109.868158","article-title":"Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient mice.","volume":"120","author":"Lewis","year":"2009","journal-title":"Circulation"},{"key":"R37-9-20211004","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.4049\/jimmunol.1000033","article-title":"Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis.","volume":"185","author":"Kyaw","year":"2010","journal-title":"J Immunol"},{"key":"R38-9-20211004","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.atherosclerosis.2005.11.033","article-title":"Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null mice.","volume":"189","author":"Faria-Neto","year":"2006","journal-title":"Atherosclerosis"},{"key":"R39-9-20211004","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1016\/j.jacc.2007.07.081","article-title":"Recombinant antibodies to an oxidized low-density lipoprotein epitope induce rapid regression of atherosclerosis in Apobec-1Low-Density Lipoprotein receptor mice.","volume":"50","author":"Schiopu","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R40-9-20211004","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1194\/jlr.M015776","article-title":"Relationship of IgG and IgM autoantibodies and immune complexes to oxidized LDL with markers of oxidation and inflammation and cardiovascular events: results from the EPIC-Norfolk Study.","volume":"52","author":"Ravandi","year":"2011","journal-title":"J Lipid Res"},{"key":"R41-9-20211004","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1194\/jlr.M600361-JLR200","article-title":"Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events.","volume":"48","author":"Tsimikas","year":"2007","journal-title":"J Lipid Res"},{"key":"R42-9-20211004","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1161\/hq0801.093587","article-title":"Human-derived antioxidized LDL autoantibody blocks uptake of oxidized LDL by macrophages and localizes to atherosclerotic lesions in vivo.","volume":"21","author":"Shaw","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R43-9-20211004","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/j.jacc.2011.07.017","article-title":"Human oxidation-specific antibodies reduce foam cell formation and atherosclerosis progression.","volume":"58","author":"Tsimikas","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R44-9-20211004","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1161\/01.ATV.0000149378.98458.fe","article-title":"Reduced in vivo aortic uptake of radiolabeled oxidation-specific antibodies reflects changes in plaque composition consistent with plaque stabilization.","volume":"24","author":"Torzewski","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R45-9-20211004","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1161\/01.ATV.0000251501.86410.03","article-title":"Increased plasma oxidized phospholipid:apolipoprotein B-100 ratio with concomitant depletion of oxidized phospholipids from atherosclerotic lesions after dietary lipid-lowering: a potential biomarker of early atherosclerosis regression.","volume":"27","author":"Tsimikas","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R46-9-20211004","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1161\/01.CIR.0000028465.52694.9B","article-title":"Lipid lowering reduces oxidative stress and endothelial cell activation in rabbit atheroma.","volume":"106","author":"Aikawa","year":"2002","journal-title":"Circulation"}],"container-title":["Current Opinion in Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00041433-201310000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T08:16:34Z","timestamp":1633508194000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00041433-201310000-00009"}},"subtitle":["biomarkers, molecular imaging and therapeutics"],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/mol.0b013e328364e85a","relation":{},"ISSN":["0957-9672"],"issn-type":[{"value":"0957-9672","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}